Compare Aptos (APT) vs Bio Protocol (BIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aptos vs Bio Protocol — how do they compare? Aptos trades at Rp10,001 (market cap Rp8,56T, Rp427,87M 24h volume), while Bio Protocol trades at Rp447.74 (market cap Rp998,02M, Rp177,99M 24h volume). The key difference: Aptos is far larger — about 8577× Bio Protocol's market cap, and Aptos's circulating supply is 857,4M / 2,1B APT (41%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 33 Days and Bio Protocol for 18 Days on average.
| APT | BIO | |
|---|---|---|
Market Cap | Rp8,56T | Rp998,02M |
Volume (24h) | Rp427,87M | Rp177,99M |
Circulating Supply | 857,4M / 2,1B APT (41%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 33 Days | 18 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aptos is trading at Rp9,982, showing bearish technical signals with moving averages indicating sell pressure, though oscillators are neutral. The current price is near support at Rp9,820, with resistance at Rp10,260. Market cap stands at Rp8.57T with 41% of max supply in circulation. No major protocol updates or ecosystem news were noted recently.
Outlook remains cautious due to bearish trends and limited fundamental catalysts. Key risks include high volatility and regulatory uncertainty, while potential support near current levels may offer short-term stability. Investors should monitor network activity for signs of adoption.
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aptos
Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.
Read more on APT →About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →
